Accelerate Diagnostics Inc. - notizie pubblicate 236 - letture 5.833
ACCELERATE DIAGNOSTICS INC.
Securities Purchase Agreement - Form 8-K
United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...
ACCELERATE DIAGNOSTICS INC.
Failure to Satisfy Listing Rule - Form 8-K
United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...
ACCELERATE DIAGNOSTICS INC.
Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit
Tucson, ariz., dec. 19, 2022/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced that the company has submitted a 510(k) application to the fda for gram-nega ...
ACCELERATE DIAGNOSTICS INC.
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results - Form 8-K
Accelerate diagnostics reports third quarter 2022 financial results tucson, ariz., november 14, 2022 -- accelerate diagnostics, inc. (nasdaq: axdx) today announced financial result ...
ACCELERATE DIAGNOSTICS INC.
Quarterly Report for Quarter Ending September 30, 2022 (Form 10-Q)
Axdx-20220930 united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☑ quarterly report pursuant to section 13 or 15(d) of the securities ex ...
ACCELERATE DIAGNOSTICS INC.
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
Tucson, ariz., nov. 14, 2022/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced financial results for the third quarter for the period ended september 30, 2 ...
ACCELERATE DIAGNOSTICS INC.
Accelerate Diagnostics scheduled call to review 2022 third quarter results
Tucson, ariz., oct. 24, 2022/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) announced today that management will host a conference call on monday, november 14, 2022, at ...
ACCELERATE DIAGNOSTICS INC.
Current Report - Form 8-K
United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...
ACCELERATE DIAGNOSTICS INC.
Securities Purchase Agreement - Form 8-K
United states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of repor ...
ACCELERATE DIAGNOSTICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ACCELERATE DIAGNOSTICS INC.
Supplemental Prospectus - Form 424B5
Tm2223426-2_424b5 - none - 9.3594199s table of contents filed pursuant to rule 424(b)(5) registration no. 333-252470 prospectus supplement (to prospectus dated february 4, 2021) 17 ...
ACCELERATE DIAGNOSTICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ACCELERATE DIAGNOSTICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ACCELERATE DIAGNOSTICS INC.
Notice of Effectiveness (Form EFFECT)
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: february 11, 2022 4:00 p.m. form: s-3 ci ...
ACCELERATE DIAGNOSTICS INC.
Initial Statement of Beneficial Ownership (Form 3)
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti